Sort
64,565 grants matching “drug discovery”
PGRN Administrative Coordination Hub, ACH (PGRN)
$514,238Kathleen M Giacomini · University Of California, San Francisco · U24 · FY2019 · GM
Mechanisms of adaptation and resistance to emerging therapies for lung cancer
$514,185Piro Lito · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Mechanisms of adaptation and resistance to emerging therapies for lung cancer
$514,185Piro Lito · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Unifying Templates, Ontologies and Tools to Achieve Effective Annotation of Bioassay Protocols
$514,129Stephan C Schurer · University Of Miami School Of Medicine · U01 · FY2019 · LM
Vagal-hypothalamic modulation of alcohol intake
$514,114Yuval Silberman · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · AA
Discovering compounds with robust pro-longevity activities
$514,100Gordon J. Lithgow · Buck Institute For Research On Aging · U01 · FY2016 · AG
Advanced approaches to protein structure prediction
$514,097Yang Zhang · University Of Michigan At Ann Arbor · R35 · FY2021 · GM
Skeletal Fragility
$514,059Sundeep Khosla · Mayo Clinic Rochester · P01 · FY2022 · AG
Biomolecular Recognition and Binding Mechanisms
$514,047Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Discovery of Hsp100-selective inhibitors for targeting multiple microbial pathogens
$514,035Michal Zolkiewski · Kansas State University · R01 · FY2019 · AI
RESEARCH PROJECT 4: Biomarker-based Evaluation of Human Interventions
$513,965Thomas A Kensler · Johns Hopkins University · P01 · FY2010 · ES
UAB Center for Clinical and Translational Science (CCTS)
$513,946Kenneth G Saag · University Of Alabama At Birmingham · KL2 · FY2017 · TR
Investigational Cancer Therapeutics Training Program
$513,912Dean F. Bajorin · Sloan-Kettering Inst Can Research · T32 · FY2019 · CA
Regulation of H2S signaling in vascular function
$513,731Jay S Naik · University Of New Mexico Health Scis Ctr · R01 · FY2024 · HL
Core N: MOLECULAR PROFILING
$513,713Ian Alexander Blair · University Of Pennsylvania · U54 · FY2013 · HL
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
$513,608Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
$513,608Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Assay of environmental toxicants for toxicity related to Alzheimer's Disease utilizing human iPSC-derived- neurons and microglia
$513,514Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2018 · ES
Genes In The Predisposition To Papillary Thyroid Carcinoma
$513,413Albert De La Chapelle · Ohio State University · P01 · FY2010 · CA
Biosynthesis and Enzymology of Antifungal Natural Products
$513,409Yi Tang · University Of California Los Angeles · R01 · FY2022 · AI
Phenotypic Assay Design and Development for Rare and Neglected Diseases
$513,391James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Clinical Consortia (Pediatric & Adult)
$513,343Stephen E Sallan · Dana-Farber Cancer Inst · P01 · FY2010 · CA
MOLECULAR APPROACHES TO DISCOVER MARINE NATURAL PRODUCT
$513,333University Of California Santa Cruz · U19 · FY2000 · CA
Preclinical Development of Therapeutics in Murine Models of Lung Cancer
$513,288Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Development of Novel Preclinical Animal Models - CAPR Infrastructure
$513,288Shyam Sharan · Division Of Basic Sciences - Nci · ZIG · FY2017 · CA